Skip to main content

Cellular Connected Drone Market Trends, Business Strategies and Opportunities With Key Players Analysis 2030


The drone market has experienced dynamic technological advancements over the last few decades. These advancements have led to the improvement in the autonomy of drones, operating ranges, capabilities, and payload sizes, and have also paved the way for various growth opportunities. The capabilities of cellular networks are expected to enhance the safety of drones for consumers, commercial applications, and government applications. The introduction of cellular network connectivity in the cellular-connected drone market has rapidly transformed the communication process between the operator and the drone. The drones are a popular option for applications such as inspections, surveillance, monitoring, and logistics, such as last-mile deliveries of parcels and medicines for remote or rural areas with less population density. Some of the stakeholders such as drone manufacturers (Ehang, Terra Drones, and DJI, among others), cellular network providers, (Verizon, AT&T Inc., and Vodafone Group, among others), and telecom equipment providers (Ericsson, Nokia, and Qualcomm, among others) are testing and developing their drones, mobile networks, and chipsets for the cellular-connected drone market, respectively.

At present, most of the drones are connected to a ground control system through a limited range of communication over an unlicensed spectrum. Hence, they are restricted to visual-line-of-sight (VLOS) operations, which limits their usage for several commercial and government applications. Cellular networks are much more reliable and scalable and provide secure connectivity compared to SATCOM and radio frequency technologies and hence are much suitable for beyond-visual-line-of-sight (BVLOS) operations.

In all the above use cases and in other VLOS applications, the use of cellular network drone is expected to enhance the efficiency of the drone by providing real-time data transmissions from embedded cameras and sensors. Mobile networks can also enable the development of new services for drones. Once the drone is cellular connected, it will be able to access changing weather forecasts and real-time information communicated from air traffic control, enabling the on-going optimization of the flight plan. Moreover, mobile connectivity can be used to share real-time flight data online and to enable remote operators to interact with a drone operator.


Connected drones could enable drone manufacturers and service companies to receive real-time alarms about failures or potential failures, thereby preventing accidents and reducing maintenance costs. By harnessing existing encryption and authentication mechanisms, mobile networks can also help secure drone operations, as well as support the identification and location needs of law enforcement agents and air traffic control systems.

The cellular-connected drone market has witnessed various forms of market dynamics across different regions of the globe over the years. Also, the drone manufacturing companies have recently witnessed a rising demand from countries such as the U.S., Australia, China, Singapore, Japan, South Korea, Germany, France, and the Netherlands, among others. The following figure represents the global market by region. It includes North America, Europe, Asia-Pacific, and Rest-of-the-World.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...